Teleflex Incorporated
(
TFX
), a worldwide provider of medical devices has announced that its
latest Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter
is now available for sale in the U.S. The company received the
510(k) clearance for the catheter from U.S. Food and Drug
Association (FDA) in May 2012.
Teleflex's latest offering will enhance the company's Arrow
catheter portfolio and strengthen its Critical Care segment. The
revenues for Critical Care segment edged up 0.2% year over year to
$254.1 million in the second quarter of 2012 while total revenues
came in at $383.3 million, up 0.6% year over year.
Management believes that performance in the most recent quarter
validates the company's focus to boost top-line and enhance its
product portfolio.
The Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter
is a development on the company's market leading Arrow FlexTip Plus
Open Tip, Single-Port epidural catheter. The Open Tip, Single-Port
epidural catheter -- the only coil-reinforced catheter -- is well
regarded in its ability to reduce complications which other
epidural catheters have not been able to prevent, such as vein
cannulations and paresthesia.
The statistical success of Open Tip, Single-Port catheter is
supported by clinical data from over a decade. The new product uses
the same technology as the Open Tip, Single Port catheter but its
addition to the Arrow FlexTip Plus will render various drug
dispersion choices in order to critically aid clinical results.
The FlexTip Plus Closed Tip, Multi-Port has a soft flexible tip
with four lateral apertures to provide exceptional kink resistance
and is based on proven technology.
The FlexTip Plus catheters are made of polyurethane unlike the
majority of other spring wound nylon catheters. The polyurethane
material provides symmetry between softness and strength for easier
catheter insertion. It also reduces unnecessary catheter movement
out of the epidural space, enhances block quality and patient
outcomes.
The new addition to the Arrow catheter family will further
support clinicians by reducing the problems faced by
anesthesiologists on a regular basis. Management therefore rightly
believes that the FlexTip Plus Closed Tip, Multi-Port can help
anesthesiologists to improve the quality and standard of patient
care.
Teleflex's latest offering is now available in Arrow brand kits
and also through Teleflex's Arrow Select Kits program for inclusion
in custom kits.
Teleflex, headquartered in Limerick, Pennsylvania, is a
manufacturer and provider of medical devices used in critical care
and surgery. Its move to divest OEM orthopedic along with the
strategy of developing new, innovative products should help improve
its financial performance in the long run. The company's focus on
profitable and consistent growth with new product introduction and
portfolio expansion is yielding results.
However,
Covidien
(
COV
),
C.R. Bard
(
BCR
) and
CareFusion
(
CFN
) which operate in similar business segments, present a tough
competitive landscape for Teleflex. Additionally, the company
operates in a seasoned regulatory environment. The demand for its
products is susceptible to healthcare reimbursement systems in the
domestic as well as the international market.
Teleflex currently retains a Zacks #4 Rank, which translates
into a short-term Sell rating.
BARD C R INC (BCR): Free Stock Analysis Report
CAREFUSION CORP (CFN): Free Stock Analysis
Report
COVIDIEN PLC (COV): Free Stock Analysis Report
TELEFLEX INC (TFX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment
Research